Divergent Fundamentals in Hong Kong Equities: From Property Overhauls to Biotech Earnings
Global Report·
- In 2026, Hong Kong stock market fundamentals exhibit significant divergence across sectors, reflecting complex economic recovery trajectories.
- The real estate sector faces ongoing restructuring pressures, with Country Garden reporting a net loss of 15.616 billion RMB in mid-2026, while the biopharmaceutical sector shows rapid expansion, highlighted by Everest MediPharm achieving 1.148 billion RMB in revenue with a year-on-year growth of 157%.
- Consumer goods, manufacturing, and traditional industries experience mixed performance due to rising costs and sluggish demand, prompting increased market interest in defensive assets like dividend low-volatility ETFs.